The importance of early development strategy and planning for biologic patent term extension.
Micheal Binns
Advertisement
Articles by Micheal Binns
Advertisement
Latest Updated Articles
- Early-Development Strategy for PTE in Biologics Given Unknowns in the Law
Published: July 3rd 2018 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly to Submit Oral GLP-1 for FDA Priority Review Program: Report
2
GCC Emerges as a New Strategic Anchor for Global Venture Capital
3
Tylenol Maker Sued While Kennedy Says No ‘Sufficient’ Evidence for Autism Link
4
Pharmaceutical Executive Daily: Novo Nordisk's Unsolicited Acquisition Proposal
5
